000 01504 a2200373 4500
005 20250512030032.0
264 0 _c19880609
008 198806s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.85.9.3145
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDe Flora, A
245 0 0 _aConversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cMay 1988
300 _a3145-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBiotransformation
650 0 4 _aDeoxyuracil Nucleotides
_xadministration & dosage
650 0 4 _aDrug Compounding
650 0 4 _aErythrocytes
_xmetabolism
650 0 4 _aFloxuridine
_xadministration & dosage
650 0 4 _aFluorodeoxyuridylate
_xadministration & dosage
650 0 4 _aHemolysis
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMicroscopy, Electron, Scanning
700 1 _aZocchi, E
700 1 _aGuida, L
700 1 _aPolvani, C
700 1 _aBenatti, U
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 85
_gno. 9
_gp. 3145-9
856 4 0 _uhttps://doi.org/10.1073/pnas.85.9.3145
_zAvailable from publisher's website
999 _c2972239
_d2972239